[Ventilatory effects in healthy men of a new analeptic drug, S 2620 (author's transl)].
D000328:Adult; D001784:Blood Gas Analysis; D002245:Carbon Dioxide; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D002628:Chemoreceptor Cells; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D010100:Oxygen; D010879:Piperazines / Q000494:pharmacology*; D012123:Pulmonary Ventilation; D012119:Respiration / Q000187:drug effects*; D012129:Respiratory Function Tests; D014227:Triazines / Q000494:pharmacology*
D000697:Central Nervous System Stimulants; D010879:Piperazines; D014227:Triazines; D002245:Carbon Dioxide; D010100:Oxygen
Effets ventilatoires chez l'homme sain d'un nouvel analeptique respiratoire, le S 2620